Agilent Technologies Inc. has announced that it has secured an exclusive license to Aktiv-Dry’s CAN-BD drying technology for nucleic acid active pharmaceutical ingredients (API’s). Can-BD is a ...
A vital stage for a wide range of pharmaceutical processes is the partial or total removal of a solvent or solvents from a product or an intermediate. The drying process required can occur in a number ...
Sponsored by Thermo Fisher Scientific – Environmental and Process Monitoring InstrumentsFeb 17 2021 Image Credit: Thermo Fisher Scientific – Environmental and Process Monitoring Instruments In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback